@tongfrog
That is true but the HIV side of the business has not generated much revenue to date
And you cannot ask the market to look at the stock the way you do. if AT1 cannot utilize the COVID opportunity, the stock is going to be punished, just like the way it was last year.
- Forums
- ASX - By Stock
- AT1
- Ann: Atomo and Access Bio renegotiate supply agreements
Ann: Atomo and Access Bio renegotiate supply agreements, page-18
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
|
|||||
Last
2.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $12.78M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 2.0¢ | $626 | 31.30K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 863999 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 152000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 863999 | 0.020 |
3 | 740000 | 0.019 |
3 | 432414 | 0.018 |
1 | 50000 | 0.016 |
2 | 266662 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 152000 | 2 |
0.022 | 53184 | 2 |
0.023 | 200000 | 1 |
0.024 | 113559 | 2 |
0.025 | 29000 | 2 |
Last trade - 15.43pm 10/09/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |